• Intersectionality of health inequities in CVD and cancer may compound inequities in cardio-oncology. • Equitable access to clinical trials is 1 of many key strategies to mitigate these health disparities. • Cardio-oncology trials should collect and report the race and ethnicity of participants, including disaggregate data on smaller minority groups. • Successful interventions consist of multilevel strategies targeting structural-, clinical-, provider-, and patient-level barriers.
No takes yet. Share an insight, caveat, or question.
Martei et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: